Cyramza

144,00 300,00 

Therapeutic VEGFR2-antibody from the original Cyramza commercial drug targeting the VEGFR2-antigen, also referred to as Cyramza antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Certificate of Analysis (CoA)* Original therapeutic expiry date PriceQuantityTotal
aliquot 102002C595845no03/2018 144,00 
-
+
144,00 
spinner
aliquot 102002C716603no06/2018 144,00 
-
+
144,00 
spinner
aliquot 102002C776706no08/2018 144,00 
-
+
144,00 
spinner
aliquot 102002C826012no01/2019 144,00 
-
+
144,00 
spinner
aliquot 102002C856707no12/2019 144,00 
-
+
144,00 
spinner
aliquot 102002C889214no06/2020 144,00 
-
+
144,00 
spinner
dilution11000,1-no- 300,00 
-
+
300,00 
spinner

Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Ramucirumab

Antigen

VEGFR2

Product Concentration [mg/mL]

1, 10

Volume per Vial [µL]

100, 200

Quantity per vial [mg]

0, 0,1, 2

Batch Number

NOT APPLICABLE, C595845, C716603, C776706, C826012, C856707, C889214, –

Certificate of Analysis (CoA)*

no

Original therapeutic expiry date

-, 01/2019, 03/2018, 06/2018, 06/2020, 08/2018, 12/2019, NOT APPLICABLE